Targeted agents: how can we improve the outcome in biliary tract cancer?
Hepatobiliary Surg Nutr
.
2013 Feb;2(1):31-3.
doi: 10.3978/j.issn.2304-3881.2012.09.03.
Authors
Donatella Marino
1
,
Federica Colombi
1
,
Dario Ribero
2
,
Massimo Aglietta
1
,
Francesco Leone
1
Affiliations
1
Department of Medical Oncology Institute for Cancer Research and Treatment, IRCC, Candiolo, Italy;
2
Department of General Surgery and Surgical Oncology, Ospedale Mauriziano "Umberto I", Torino, Italy.
PMID:
24570912
PMCID:
PMC3924636
DOI:
10.3978/j.issn.2304-3881.2012.09.03
No abstract available